1http://dx.doi.org/10.20396/bjos.v20i00.8661817 Volume 20 2021 e211817 Original Article 1 Master and Doctoring in Publich Health from the State University of Feira de Santana - UEFS, Bahia, Brazil. Specialist in Oral Pathology from São Leopoldo Mandic, São Paulo, Brazil. ² Dental Surgeon from the State University of Feira de Santana - UEFS, Bahia, Brazil. 3 Dental Surgeon from the State University of Feira de Santana - UEFS, Bahia, Brazil. 4 Dental Surgeon from Metropolitan Union for Education and Culture – UNIME, Lauro de Freitas, Bahia, Brazil. 5 Master and Specialist in Oral and Maxillofacial Surgery and Traumatology from the State University of Pernambuco, PhD in Stomatology from the University of Paraíba, Professor at the State University of Feira de Santana (BA) and UNIME - College of Agrarian Health Sciences (BA). * Corresponding author: Sheinaz Farias Hassam Rua Juca Marques, 401 Campo Formoso, Bahia, Brazil 44790-000 Email: sheinazhassam@hotmail.com Received for publication: October 30, 2020 Accepted: January 7, 2021 Prevalence of tumours of the maxillomandibular complex diagnosed in a reference center in Brazil Alessandra Laís Pinho Valente Pires1 , Izana Santos Borges Nascimento2, Ana Letícia Marques de Souza Assis³, Sheinaz Farias Hassam4,* , Jener Gonçalves de Farias5 Tumors of the maxillomandibular complex are a heterogeneous group of lesions with a wide spectrum of clinical and histopathological characteristics. Aim: To evaluate the prevalence of odontogenic and non-odontogenic tumors associated with maxillary bones in a Reference Center for Oral Lesions. Methods: A cross-sectional study based on the medical records of a Reference Center for Oral Lesions at the State University of Feira de Santana, from 2006 to 2018. The data was initially analyzed in a descriptive manner. For bivariate analysis, Pearson’s chi-square test was applied. The level of significance was set at 5%, where p≤ 0.05 is considered significant. Results: The prevalence of tumors was 2.27%. The average age of the individuals was 22.2 (± 15.1) years, the majority being up to 39 years (79.59%) and female (69.40%). A statistically significant difference was observed in relation to age (p = 0.00), as well as regarding the location of tumors in the anterior or posterior region (p = 0.02). Odontogenic tumors were benign, with odontoma being most frequent (46.90%), followed by ameloblastoma (16.30%). As  for the non-odontogenic, neurofibroma (4.10%) and osteoma (4.10%) were the most common across the benign, while osteosarcoma accounted for 6.10% of cases. Conclusion: Odontogenic tumors were the most frequent in women, with age up to 39 years, odontoma being most common in the posterior region of the mandible. Among non- odontogenic tumors, central neurofibroma and osteoma were the most common. Osteosarcoma was more frequent in men over 40 years old and in the mandible region. KEYWORDS: Diagnosis. Prevalence. Pathology, oral. Cross- sectional studies. Epidemiology. mailto:sheinazhassam@hotmail.com https://orcid.org/0000-0002-6848-8992 https://orcid.org/0000-0002-8567-6207 2 Pires et al. Introduction The maxillomandibular complex is subject to the development of several conditions1. Intraosseous lesions of the jaws constitute a heterogeneous group of lesions that present a wide spectrum of clinical and histopathological characteristics, ranging from cysts, tumors and bone-associated lesions2. The first internationally accepted classification for maxillofacial lesions was pub- lished by the World Health Organization (WHO) in 1971, which has been modified over the years (1992 and 2005), in an attempt to better define its diagnostic criteria3. The most recent WHO edition, in 2017, introduced some changes in the 2005 clas- sification, and, in addition to the return of odontogenic cysts, two new entities were included: sclerosing odontogenic carcinoma and primordial odontogenic tumor4. This  new classification focuses on those that are biologically benign or malignant, signaling a simplification of the previous version5. Odontogenic tumors form a complex group of lesions that range from hamartomatous or non-neoplastic proliferations to malignant neoplasms with metastatic capacity6, originating from the remnants of the tooth-forming apparatus7. Regarding non-odon- togenic tumors, their classification is not yet well established, whether this would be according to the original tissue or according to its topography. According to the WHO, these tumors have a predilection for the mandibular bone, but some of the lesions, such as chondroma, chondrosarcoma and osteosarcoma, although occurring in the mandible, do not essentially show a greater predilection for this site8,9. In Brazil, epidemiological studies show that, among all diagnosed oral lesions, 1.3 to 4.8% are odontogenic tumours10, presenting results similar to other Latin American countries, such as Chile and Mexico11. Regarding non-odontogenic tumors, a study conducted in Queensland, Australia, showed that benign non-odontogenic lesions were 6.8 times more likely to appear than malignant non-odontogenic lesions12. National epidemiological studies related to bone lesions are scarce13. These studies have an important relevance for the knowledge of the population profile, as well as the injuries that can occur in the stomatognathic system, helping in the early diagnosis and treat- ment. Thus, this study aimed to describe the prevalence of odontogenic and non-odon- togenic tumors of the maxillomandibular complex in a Reference Center in Brazil. Materials And Methods Design, area of study and characterization of the sample This is a retrospective cross-sectional study, based on secondary data from medical records and conclusive anatomopathological reports of individuals diagnosed at a Reference Center for Oral Lesions (CRLB) in the Department of Health Sciences, State University of Feira de Santana (UEFS). This research was registered and approved by Research Ethics Committee of the Institution where it was carried out (Protocol Number: 015/2008, CAAE 0015.0.059.000-08). Cases of odontogenic and non-odontogenic tumors were selected between 2006 to 2018 and classified according to the current WHO classification (2017)5. The criteria 3 Pires et al. for exclusion were: medical records that had only descriptive reports; reports with the same registration number; and different diagnoses for the same patient. Data collection and selected variables This collection was performed by a single examiner trained to complete the collection worksheet. Data regarding gender, age, anatomical site (maxilla versus mandible; pos- terior versus anterior) and histopathological type were obtained from patients’ records, which also contained the Informed Consent Form duly signed by the patient or guardian. Data analyses The data was initially analyzed descriptively. For the bivariate analysis, the normality of the data was verified with the Kolmogorov-Smirnov test. Then, Pearson’s chi-square test was applied for categorical variables. The level of significance used was 5%, where p≤ 0.05 was considered significant. Analysis was carried out using the Statistical Pack- age for the Social Sciences software, version 17.0. (SPSS Inc., Chicago, IL, USA). Results During the study period, all 2,156 histopathological reports of oral lesions, diagnosed at CRLB, were evaluated. Of these, 290 were diagnosed with some type of intraos- seous lesion, and 49 were conclusive for tumors of the maxillofacial complex, repre- senting a prevalence of 2.27%. The mean age of the individuals was 22.2 (± 15.1) years. The majority, 39 (79.59%), were in the group of up to 39 years and were female (69.40%). Statistically significant differences were observed between tumors of the maxillomandibular complex and other intraosseous lesions in relation to age (p = 0.00), as well as regarding the ana- tomical site (anterior versus posterior) (p = 0.02) (Table 1). Table 1. Bivariate analysis of tumors of the maxillomandibular complex and other intraosseous lesions, CRLB, UEFS, 2006-2018. Variables Tumors Other intraosseous lesions n (%) n (%) p Age range Up to 39 years 39 (79.59%) 123 (51.10%) 0.00* From 40 years 10 (20.41%) 118 (48.90%) Gender Female 34 (69.40%) 164 (68.00%) 0.85 Male 15 (30.60%) 77 (32.00%) Anatomical site (Mandible vs Maxilla) Mandible 27 (55.10%) 140 (58.10%) 0.70 Maxilla 22 (44.90%) 101 (41.90%) Anatomical site (Posterior vs Anterior) Anterior 27 (55.10%) 90 (37.30%) 0.02* Posterior 22 (44.90%) 151 (62.70%) * p<0.05 4 Pires et al. Benign odontogenic tumors (39) were the most common. Odontoma was the most frequent 23 (46.90%), followed by ameloblastoma 08 (16.30%). Cementoblastoma 3 (6.10%) was the third most common. No malignant odontogenic tumor was diag- nosed. As for non-odontogenic tumors (10), central neurofibroma 02 (4.10%) and osteoma 02 (4.10%) were the most common, while osteosarcoma was the malignant tumor present in 3 (6.10%) of the cases (Table 2). Table 2. Tumors of the maxillomandibular complex according to frequency and percentage, CRLB, UEFS, 2006-2018. Tumors of the maxillomandibular complex n % Odontogenic tumors Odontoma 23 46.90 Ameloblastoma 08 16.30 Cementoblastoma 03 6.10 Myxoma 02 4.10 AOT* 02 4.10 CEOT** 01 2.05 Non-Odontogenic tumors Benign Central neurofibroma 02 4.10 Osteoma 02 4.10 Fibroblastoma 01 2.05 Hemangiopericitoma 01 2.05 Malignant Osteossarcoma 03 6.10 Small round cell sarcoma 01 2.05 Total 49 100 * Adenomatoid odontogenic tumor; ** Calcifying epithelial odontogenic tumor Table 3 shows the distribution of odontogenic and non-odontogenic tumors by age, gender and location. Table 3. Distribution of odontogenic and non-odontogenic tumors according to age, gender and location, CRLB, UEFS, 2006-2018. Tumors Age (years) Gender Location 1-39 ≥ 40 Female Male Maxilla Mandible Odontogenic Odontoma 21 02 16 08 08 08 Ameloblastoma Unicystic 05 00 05 00 00 05 Ameloblastoma 02 01 01 02 00 03 Cementoblastoma 02 01 03 00 01 02 Mixoma 02 00 02 00 00 02 AOT* 01 01 01 01 01 01 CEOT** 01 01 01 01 01 01 Continue 5 Pires et al. Tumors Age (years) Gender Location 1-39 ≥ 40 Female Male Maxilla Mandible Non-odontogenic Benign Centra Neurofibroma 01 01 01 01 00 02 Osteoma 00 02 01 01 02 00 Fibroblastoma 01 00 01 00 01 00 Hemangiopericitoma 01 00 01 00 00 01 Malignant Osteossarcoma 01 02 01 02 01 02 Small round cell sarcoma 01 00 00 01 00 01 * Adenomatoid odontogenic tumor; ** Calcifying epithelial odontogenic tumor Discussion In this study, intraosseous lesions of the jaws showed a prevalence of 13.45%, based on the 13-year analysis. A low prevalence (25%) was reported by Jaafari-Ashkavandi and Akbari2 (2017) after 22-year of collecting data, which differs from the findings of Ali14 (2011), whose percentage was 31% in 5-year follow-up. Most tumors were of odontogenic origin, corroborating with Parkins  et  al.15 (2007). However, a study conducted in Ghana found a greater number of non-odontogenic tumors. This can be justified by the fact that non-aggressive odontogenic lesions, such as odontomas, have not been diagnosed, since only symptomatic patients with facial edema were included in the sample16. Odontogenic tumors corresponded to 1.80% of all cases, a result that is similar to other studies17,18 and these lesions mainly occurred in female patients. There are studies in the literature reporting similar occurrence between males and females19; however, some studies have reported a higher prevalence in males20,21, while others also have shown females to be more affected22, corroborating with our result. There is no plausible explanation proven for these differences. Souto et al.23 (2014) described that a higher prevalence in women can be explained through the fact that women are more likely to seek healthcare, making these lesions more detectable and raising the number of cases in the female gender. The age group with the most cases was the fourth decade of life, as noted by Kebede, et al.21 (2017). In contrast, Pereira, et al.24 (2010) described a higher frequency in individuals over 50 years old. The variation may be related to the different samples and populations analyzed. Malignant odontogenic tumors were not diagnosed in this study. They are extremely rare lesions, with reported incidences of 1.1%25 and 1.18%26. In Silvera et al.27 (2021) study, the malignant lesions were more common in males and in the mandible, affect- ing individuals of 55 ± 21.6 years. Overall, odontomas were the most prevalent of the group, followed by unicystic ame- loblastoma, similar to the data from previous publications19. However, AlSheddi et al.28 Continuation 6 Pires et al. (2015) found that odontogenic keratocysts were the most common, followed by ameloblastomas, which can be justified by the difference in the WHO classification, as they used the third edition (2005), which classifies keratocysts as tumors, whereas we used the fourth, which classifies them as a cyst. In some studies, myxoma was the third most common odontogenic tumour27,29. In our study, adenomatoid odontogenic tumor (AOT) and myxoma had a similar fre- quency (4.10% each) and were in the fourth position. Calcifying epithelial odontogenic tumor (CEOT) comprised a lower occurrence (2.05%). Ali14 (2011) observed that CEOT appears as the least frequent among odontogenic tumors. The majority of the studies on odontogenic tumors demonstrated a strong predilection for the mandible, especially the posterior region20,30. Jaw-specific genetic mechanisms that regulate the evolution and development of upper and lower dentitions appear to dif- fer and this may provide a partial explanation to the difference in the incidence of odon- togenic tumors in the mandible versus maxilla31. However,  Açikgoz, et al.32 (2012) and Kambalimath,  et  al.33 (2014), suggested involvement in the maxilla. Regarding  odon- toma, the highest prevalence was in the maxilla, being in line with other authors19,28. It is worth mentioning that among the group of non-odontogenic tumors, neurofi- broma and osteoma were the most common among the benign, diverging from the findings of Rodrigues,  et  al.34 (2010) and Johnson,  et  al.12 (2013), in which the cen- tral giant cell granuloma was the most frequent. Osteosarcoma was the most fre- quent among the malignant. These are rare, aggressive, with a high mortality rate35. Jaafari-Askavandi and Akbari2 (2017) pointed out that this lesion corresponded to 28.1% of the neoplasms in their findings. Due to this being a descriptive study, the variables analyzed do not allow for inferring causality, requiring further longitudinal studies. However, the results contribute to a better understanding of the clinical-epidemiological profile of individuals and in the development of strategies and actions destined towards diagnosis and treatment of such lesions. The present study was carried out in a reference center, in which oral pathologists issued a histopathological diagnosis, enabling the evaluation of lesions that affect the jaws. New epidemiological studies on tumors of the maxillomandibular complex should be carried out in Brazil, in order to obtain greater knowledge surrounding their behavior, thus improving their diagnosis and treatment. In conclusion, the prevalence of tumors of the maxillomandibular complex was 2.27%. Odontogenic tumors were the most frequent in women, aged up to 39 years, odontoma being the most common in the posterior region of the mandible. Among  non-odon- togenic tumors, central neurofibroma and osteoma were the most common. Osteosarcoma was more frequent in men over 40 years old and in the mandible region. References 1. Zanda MJ, Poleti ML, Fernandes TMF, Sathler R, Sant’Ana E, Consolaro A. [Benign cementoblastoma: case report]. Rev Fac Odontol Lins. 2012;22(1):55-9. doi: 10.15600/2238-1236/ fol.v22n1p55-59. Portuguese. 7 Pires et al. 2. Jaafari-Ashkavandi Z, Akbari B. Clinicopathologic study of intra- osseous lesions of the jaws in southern iranian population. J Dent Shiraz Univ Med Sci., 2017 Dec;18(4):259-64. 3. Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch. 2018 Mar;472(3):331-9. doi: 10.1007/s00428-017-2182-3. 4. EI-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours:9. 4th ed. Lyon, France: International Agency for Research on Cancer Press; 2017. 5. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: odontogenic and maxillofacial bone tumors. Head and Neck Pathol. 2017 Mar;11(1):68-77. doi: 10.1007/s12105-017-0794-1. 6. Varkhede A, Tupkari JV, Sardar M. Odontogenic tumors: a study of 120 cases in an Indian teaching hospital. Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16(7):e895-9. doi: 10.4317/medoral.17251. 7. Nalabolu GRK, Mohiddin A, Hiremath SKS, Manyam R, Bharath TS, Raju PR. Epidemiological study of odontogenic tumours: An institutional experience. J Infect Public Health. 2017 May-Jun;10(3):324-30. doi: 10.1016/j.jiph.2016.05.014. 8. Cleven AHG, Schreuder WH, Groen E, Kroon HM, Baumhoer D. Molecular findings in maxillofacial bone tumours and its diagnostic value. Virchows Archiv. 2020 Jan;476(1):159-74. doi: 10.1007/ s00428-019-02726-2. 9. Sivapathasundharam B, Biswas PG, Preethi S. The World Health Organization classification of odontogenic and maxillofacial bone tumors: an appraisal. J Oral Maxillofac Pathol. 2019 May- Aug;23(2):178-86. doi: 10.4103/jomfp.JOMFP_211_19. Erratum on: J Oral Maxillofac Pathol. 2019 Sep-Dec;23(3):483. doi: 10.4103/0973-029X.273566. 10. Louredo BVR, Freitas CTS, Câmara J, Libório-Kimura TN. [Epidemiological study of odontogenic lesions from the Department of Pathology and Legal Medicine, Federal University of Amazonas]. Rev Bras Odontol. 2017;74(2):126-32. doi: 10.18363/rbo.v74n2.p.126. Portuguese. 11. Ledesma-Montes C, Mosqueda-Taylor A, Carlos-Bregni R, de Leon ER, Palma-Guzman JM, Perez- Valencia C, et al. Ameloblastomas: a regional Latin-American multicentric study. Oral Diseases. 2007 May;13(3):303-7. doi: 10.1111/j.1601-0825.2006.01284.x. 12. Johnson NR, Savage NW, Kazoullis S, Batstone MD. A prospective epidemiological study for odontogenic and non-odontogenic lesions of the maxilla and mandible in Queensland. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Apr;115(4):515-22. doi: 10.1016/j.oooo.2013.01.016. 13. Farias JG, Souza RCA, Hassam SF, Cardoso JA, Ramos TCF, Santos HKA. Epidemiological study of intraosseous lesions of the stomatognathic or maxillomandibular complex diagnosed by a Reference Centre in Brazil from 2006-2017. Br J Oral Maxillofac Surg. 2019 Sep;57(7):632-7. doi: 10.1016/j.bjoms.2019.05.003. 14. Ali MA. Biopsied jaw lesions in Kuwait: a six-year retrospective analysis. Med Princ Pract. 2011;20(6):550-5. doi: 10.1159/000330023. 15. Parkins GE, Armah G, Ampofo P. Tumours and tumour-like lesions of the lower face at Korle Bu Teaching Hospital, Ghana--an eight year study. World J Surg Oncol. 2007 May 7;5:48. doi: 10.1186/1477-7819-5-48. 16. Parkins GE, Armah GA, Tettey Y. Orofacial tumours and tumour-like lesions in Ghana: a 6-year prospective study. Br J Oral Maxillofac Surg. 2009 Oct;47(7):550-4. doi: 10.1016/j. bjoms.2008.11.003. 17. Osterne RLV, Brito RGM, Alves APNN, Cavalcante RB, Souza FB. Odontogenic tumors: a 5-year retrospective study in a Brazilian population and analysis of 3406 cases reported in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Apr;111(4):474-81. doi: 10.1016/j. tripleo.2010.10.018. https://www.ncbi.nlm.nih.gov/pubmed/?term=Sivapathasundharam%20B%5BAuthor%5D&cauthor=true&cauthor_uid=31516220 https://www.ncbi.nlm.nih.gov/pubmed/?term=Biswas%20PG%5BAuthor%5D&cauthor=true&cauthor_uid=31516220 https://www.ncbi.nlm.nih.gov/pubmed/?term=Preethi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=31516220 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714253/ 8 Pires et al. 18. da-Costa DO, Maurício AS, de-Faria PA, da-Silva LE, Mosqueda-Taylor A, Lourenço SD. Odontogenic tumors: a retrospective study of four Brazilian diagnostic pathology centers. Med Oral Patol Oral Cir Bucal. 2012 May 1;17(3):e389-94. doi: 10.4317/medoral.17630. 19. Chrysomali E, Leventis M, Titsinides S, Kyriakopoulos V, Sklavounou A. Odontogenic tumors. J Craniofac Surg. 2013 Sep;24(5):1521-5. doi: 10.1097/SCS.0b013e3182997aaf. 20. Ramachandra S, Shekar PC, Prasad S, Kumar KK, Reddy GS, Prakash KL et al. Prevalence of odontogenic cysts and tumors: A retrospective clinico-pathological study of 204 cases. SRM J Res Dent Sci. 2017;5(3):170-3. doi: 10.4103/0976-433X.138727. 21. Kebede B, Tare B, Bogale B, Alemseged F. Odontogenic tumors in Ethiopia: eight years retrospective study. BMC Oral Health. 2017 Feb;17(1):54. doi: 10.1186/s12903-017-0347-8. 22. Osterne RL, Brito RG, Alves AP, Cavalcante RB, Sousa FB. Odontogenic tumors: a 5-year retrospective study in a Brazilian population and analysis of 3406 cases reported in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Apr;111(4):474-81. doi: 10.1016/j. tripleo.2010.10.018. 23. Souto MLS, Piva MR, Martins-Filho PRS, Takeshita WM. [Maxillofacial lesions: a survey of 762 cases from the Federal University of Sergipe, Brazil]. Rev Odontol UNESP. 2014;43(3):185-90. doi: 10.1590/ rou.2014.029. Portuguese. 24. Pereira JV, Figueirêdo DU, Souza EA, Holmes TSV, Gomes DQC, Cavalcanti AL. [Prevalence of odontogenic cysts and tumors in patients treated at the Paraíba Health Assistance Foundation: a retrospective study]. Arq Odontol. 2010;46(2):75-81. Portuguese. 25. Mosqueda-Taylor A, Ledesma-Montes C, Caballero-Sandoval S, Portilla-Robertson J, Ruíz-Godoy Rivera LM, Meneses-García A. Odontogenic tumors in Mexico: a collaborative retrospective study of 349 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Dec;84(6):672-5. doi: 10.1016/ s1079-2104(97)90371-1. 26. Fernandes AM, Duarte EC, Pimenta FJ, Souza LN, Santos VR, Mesquita RA, et al. Odontogenic tumors: A study of 340 cases in a Brazilian population. J Oral Pathol Med. 2005 Nov;34(10):583-7. doi: 10.1111/j.1600-0714.2005.00357.x. 27. Silveira FM, Macedo CCS, Borges CMV, Mauramo M, Vasconcelos ACU, Soares AB, et al. Odontogenic tumors: an 11-year international multicenter study. Oral Dis. 2021 Mar;27(2):320-4. doi: 10.1111/odi.13550.  28. Alsheddi MA, Alsenani MA, Aldosarib AW. Odontogenic tumors: analysis of 188 cases from Saudi Arabia. Ann Saudi Med. 2015;35(2):146-50. doi: 10.5144/0256-4947.2015.146. 29. Pontes CGC, Trindade Neto AI, Ribeiro ILH, Sarmento VA, Santos JN, Azevedo RA. [Epidemiology of odontogenic cysts and tumors treated under general anesthesia in a philanthropic hospital in Salvador, Bahia]. Rev Cir Traumatol Buco-Maxilo-Fac. 2012 Jan-Mar;12(1):93-100. Portuguese. 30. Mascitti M, Togni L, Troiano G, Caponio VCA, Sabatucci A, Balercia A, et al. Odontogenic tumours: A 25-year epidemiological study in the Marche region of Italy. Eur Arch Otorhinolaryngol. 2020 Feb;277(2):527-38. doi: 10.1007/s00405-019-05683-3. 31. Ferguson CA, Tucker AS, Sharpe PT. Temporospatial cell interactions regulating mandibular and maxillary arch patterning. Development. 2000 Jan;127(2):403-12. 32. Açikgöz A, Uzun-bulut E, Özden BK, Gunduz K. Prevalence and distribution of odontogenic and nonodontogenic cysts in a Turkish Population. Med Oral Patol Oral Cir Bucal. 2012 Jan;17(1):e108-15. doi: 10.4317/medoral.17088. 33. Kambalimath DH, Kambalimath HV, Agrawal SM, Singh M, Jain N, Anurag B, et al. Prevalence and distribution of odontogenic cyst in Indian population: a 10 year retrospective study. J Maxillofac Oral Surg. 2014 Mar;13(1):10-5. doi: 10.1007/s12663-012-0450-y. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074140/ 9 Pires et al. 34. Rodrigues TLC, Rodrigues FG, Carodos AB, Gandelmann IHA, Cavalcante MAA. [Benign tumors of the jaws: a 10-year retrospective analysis]. Rev Cir Traumatol Buco-Maxilo-fac. 2010;10(2):91-6. Portuguese. 35. ElKordy MA, ElBaradie TS, ElSebai HI, KhairAlla SM, Amin AAE. Osteosarcoma of the jaw: Challenges in the diagnosis and treatment. J Egypt Natl Canc Inst. 2018 Mar;30(1):7-11. doi: 10.1016/j. jnci.2018.02.001. Erratum in: J Egypt Natl Canc Inst. 2018 Sep;30(3):123.